|
|
|
| TPCE Ccombined with CT Guided Percutaneous Microwave Ablation for Advanced Non-small Cell Lung Cancer |
| RAN Li, ZHANG Rong-hua, QIN HE-ping |
| Chongqing Yunyang Hospital Aspiration Medicine,Chongqing 404500 |
|
|
|
|
Abstract 【Objective】 To investigate the clinical effect and survival rate of TPCE combined with CT guided percutaneous microwave ablation in the treatment of advanced non-small cell lung cancer (NSCLC).【Methods】 The clinical data of 116 patients with advanced lung cancer in our hospital were analyzed retrospectively. According to different treatment methods, they were divided into observation group and control group, 58 cases in each group. TPCE was given to the patients in the control group, and tpce combined with percutaneous microwave ablation (PMAT) was used in the observation group. Three months after treatment, contrast-enhanced CT was performed to compare the therapeutic effect of the two groups. Serum CEA, CA125 and VEGF levels were compared before and after treatment. The survival rates of 1,2,3 years were recorded.【Results】 The disease control rate of the observation group was 84.5% (49 / 58), higher than that of the control group (67.2%) (39 / 58), the difference was statistically significant (χ2=4.708,P<0.05). Three months after treatment, the serum CEA, CA125 and VEGF levels of the two groups decreased, and the difference was statistically significant (P<0.05). The 1,2,3-year survival rate in the observation group was significantly higher than that in the control group (P<0.05).【Conclusion】 TPCET combined with PMAT sequential treatment can significantly improve the therapeutic effect of NSCLC and improve the survival rate of patients.
|
|
Received: 23 October 2018
|
|
|
|
|
|
[1] 姚晓军, 刘伦旭. 肺癌的流行病学及治疗现状[J].现代肿瘤医学, 2014, 3(8):1982-1986.
[2] 刘江泽, 刘四斌, 李英,等. 支气管动脉化疗栓塞结合同步放疗、静脉化疗治疗中心型肺癌[J].介入放射学杂志, 2012, 21(4):297-300.
[3] 谢韬, 许军, 朱先海,等. CT引导下经皮肺穿刺微波消融治疗非小细胞肺癌(36例临床疗效分析)[J].影像诊断与介入放射学, 2017, 26(4):314-319.
[4] 刘单, 邓述恺. 铂类药物与肺癌化疗的临床研究进展[J].西南军医, 2015,17(1):62-65.
[5] Zhang J, Zhou S, Tang L, et al. WAVE1 gene silencing via RNA interference reduces ovarian cancer cell invasion, migration and proliferation.[J].Gynecol Oncol,2013, 130(2):354-361.
[6] 姜红岩, 唐文茜, 李金英,等. 调强放疗联合同步替吉奥化疗治疗直肠癌不良反应观察及干预[J].中国临床医生杂志, 2016, 44(2):47-50.
[7] 黄优华,沈涛,徐强,等.支气管动脉灌注化疗与栓塞治疗中晚期肺癌的疗效观察[J].现代生物医学进展,2013,13(34):6711-6714.
[8] Chen JH, Kuo YH, Luh HP. Optimal policies of non-cross-resistant chemotherapy on Goldie and Coldman's cancer model[J].Math Biosci, 2013, 245(2):282-298.
[9] 柯要军. 介入支气管动脉灌注化疗联合动脉栓塞治疗对中心型肺癌肿瘤标志物的影响[J].海南医学院学报, 2015, 21(1):117-119.
[10] 黄世幸. 纤支镜检查联合痰液CYFRA21、CEA、CA125对肺癌的诊断价值[J].临床肺科杂志, 2017, 22(7):1222-1225.
[11] 王广丽, 崔丁也, 邓凯,等. 非小细胞肺癌VEGF表达与CT能谱成像相关性的初步研究[J].临床放射学杂志, 2017, 36(8):1111-1114. |
| [1] |
. [J]. JOURNAL OF CLINICAL RESEARCH, 2020, 37(5): 783-785. |
|
|
|
|
2020, Vol. 37 
